Demographic and clinical profile of systemic and cutaneous Polyarteritis nodosa in a group of pediatric patients in Medellin, 2010-2019
DOI:
https://doi.org/10.17533/udea.iatreia.122Keywords:
pediatrics, polyarteritis nodosa, vasculitisAbstract
Objective: To describe the main demographic and clinical characteristics of patients who were diagnosed with childhood polyarteritis nodosa (PAN).
Methods: A descriptive study was conducted using retrospective data
Results: The clinical registries from patients under 18th years with vasculitis or PAN diagnosis attended between 2010 and 2019 in two Medical Centers from Medellín were obtained. Nineteen patients were included: eleven classified as cutaneous PAN (PANC) according to the definition of the European League Against Rheumatism and the European Society of Pediatric Rheumatology and eight as systemic AN according to Ankara 2008 Criteria. 57.9% were male. The median age at diagnosis was ten years (3-17), and the median follow-up period was 15 months (0-105). The most common clinical characteristics were ubcutaneous nodules (84.2%), fever (57.9%), arthralgias (57.9%), and calf pain (52.6%). SPAN patients had more frequent weight loss and lower hemoglobin. Five patients had ulcers (26.3%), four of them with CPAN; two patients had lingual necrosis (10.5%), and two digital necrosis (10.5%), all of them also with CPAN. CRP mean was 10.2 mg/dl (0.33-45.3) and mean erythrocyte sedimentation rate (ESR) was 74 mm/h (15-127 mm/h). Meningeal enhancing, intrahepatic, and mesenteric aneurism, among others, were reported in diagnostic images. All patients required treatment with systemic glucocorticoid. None of the patients died during the follow-up period.
Conclusions: In this pediatric series from Medellín-Colombia, PAN was more common in boys of school age. CPAN was more frequent than SPAN. The clinical characteristics most reported were subcutaneous nodules, myalgias, arthralgias, and calf pain. Although CPAN has been considered a benign disease, these patients may require systemic glucocorticoid and immunosuppressive therapy.
Downloads
References
(1) De Virgilio A, Greco A, Magliulo G, Gallo A, Ruoppolo G, Conte M, et al. Polyarteritis nodosa: A contemporary overview. Autoimmun Rev. 2016 Jun;15(6):564-70. DOI 10.1016/j.autrev.2016.02.015.
(2) Mossberg M, Segelmark M, Kahn R, Englund M, Mohammad AJ. Epidemiology of primary systemic vasculitis in children: a population-based study from southern Sweden. Scand J Rheumatol. 2018 Jul;47(4):295-302. DOI 10.1080/03009742.2017.1412497.
(3) Ozen S, Bakkaloglu A, Dusunsel R, Soylemezoglu O, Ozaltin F, Poyrazoglu H, et al. Childhood vasculitides in Turkey: a nationwide survey. Clin Rheumatol. 2007 Feb;26(2):196-200. DOI 10.1007/s10067-006-0266-6.
(4) Guillevin L. Polyarteritis nodosa. In: Bridges S, Ball G, editors. Vasculitis. 2nd ed. Oxford: Oxford University; 2008. p. 335–53.
(5) Ozen S. The changing face of polyarteritis nodosa and necrotizing vasculitis. Nat Rev Rheumatol. 2017 Jun;13(6):381-6. DOI 10.1038/nrrheum.2017.68.
(6) Ozen S, Anton J, Arisoy N, Bakkaloglu A, Besbas N, Brogan P, et al. Juvenile polyarteritis: results of a multicenter survey of 110 children. J Pediatr. 2004 Oct;145(4):517-22. DOI 10.1016/j.jpeds.2004.06.046.
(7) Özen S, Sönmez HE, Demir S. Pediatric forms of vasculitis. Best Pract Res Clin Rheumatol. 2018 Feb;32(1):137-147. DOI 10.1016/j.berh.2018.09.007.
(8) Eleftheriou D, Dillon MJ, Tullus K, Marks SD, Pilkington CA, Roebuck DJ, et al. Systemic polyarteritis nodosa in the young: a single-center experience over thirtytwo years. Arthritis Rheum. 2013 Sep;65(9):2476-85. DOI 10.1002/art.38024.
(9) Minkowitz G, Smoller BR, McNutt NS. Benign Cutaneous Polyarteritis Nodosa: Relationship to Systemic Polyarteritis Nodosa and to Hepatitis B Infection. Arch Dermatol. 1991;127(10):1520–3. DOI 10.1001/archderm.1991.01680090084009.
(10) Diaz Perez JL, Winkelmann RK. Cutaneous Periarteritis Nodosa. Arch Dermatol. 1974 Sep;110(3):407–14.
(11) Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis. 2010 May;69(5):798-806. DOI 10.1136/ard.2009.116657.
(12) Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006;65(7):936–41. DOI 10.1136/ard.2005.046300.
(13) Nakamura T, Kanazawa N, Ikeda T, Yamamoto Y, Nakabayashi K, Ozaki S, et al. Cutaneous polyarteritis nodosa: revisiting its definition and diagnostic criteria. Arch Dermatol Res. 2009;301(1):117–21. DOI 10.1007/s00403-008-0898-2.
(14) Dolezalova P, Price-Kuehne FE, Özen S, Benseler SM, Cabral DA, Anton J, et al. Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS). Ann Rheum Dis. 2013;72(10):1628–33. DOI 10.1136/annrheumdis-2012-202111.
(15) Gómez M, Danglot C, Vega L. Cómo seleccionar una prueba estadística. Rev Mex Pediatría. 2013;80(2):81–5.
(16) Gouda MA. Common Pitfalls in Reporting the Use of SPSS Software. Med Princ Pract. 2015;24(3):300. DOI 10.1159/000381953.
(17) Guarnizo P. Vasculitis en la infancia. In: Correa JA, Gómez JF, Posada R, editors. Fundamentos de Pediatría Tomo II. 4th ed. Medellín: CIB; 2012. p. 201–7.
(18) Jelusic M, Vikic-Topic M, Batinic D, Milosevic D, Malenica B, Malcic I. Polyarteritis nodosa in Croatian children: a retrospective study over the last 20 years. Rheumatol Int. 2013;33(12):3087–90. DOI 10.1007/s00296-012-2595-x.
(19) Falcini F, La Torre F, Vittadello F, Rigante D, Martini G, Corona F, et al. Clinical overview and outcome in a cohort of children with polyarteritis nodosa. Clin Exp Rheumatol. 32(3 Suppl 82):S134-7.
(20) Sharma A, Pinto B, Dhooria A, Rathi M, Singhal M, Dhir V, et al. Polyarteritis nodosa in north India: clinical manifestations and outcomes. Int J Rheum Dis. 2017;20(3):390–7. DOI 10.1111/1756-185X.12954.
(21) Pagnoux C, Henegar C, Mahr A, Cohen P. Clinical Features and Outcomes in 348 Patients with Polyarteritis Nodosa a Systematic Retrospective Study of Patients Diagnosed Between 1963 and 2005 and Entered into the French Vasculitis Study Group Database. 2010;62(2):616–26. DOI 10.1002/art.27240.
(22) Mondal R, Sarkar S. Childhood polyarteritis nodosa: a prospective multicentre study from eastern India. Indian J Pediatr. 2014;81:371–4. DOI 10.1007/s12098-013-1256-8.
(23) Shirai T, Shirota Y, Fujii H, Ishii T, Harigae H. Four distinct clinical phenotypes of vasculitis affecting mediumsized arteries. Scand J Rheumatol. 2019;48(4):308–14. DOI 10.1080/03009742.2018.1551965.
(24) Günal N, Kara N, Cakar N, Koçak H, Kahramanyol O,Cetinkaya E. Cardiac involvement in childhood polyarteritis nodosa. Int J Cardiol. 1997 Aug;60(3):257–62. DOI 10.1016/S0167-5273(97)00119-8.
(25) Özçakar Z, Fitös S, Yıldız A, Yalçınkaya F. Childhood polyarteritis nodosa: diagnosis with non-invasive imaging techniques. Clin Rheumatol. 2017;36:165–71. DOI 10.1007/s10067-016-3440-5.
(26) de Boysson H, Guillevin L. Polyarteritis Nodosa Neurologic Manifestations. Neurol Clin. 2019 May;37(2):345-357. DOI 10.1016/j.ncl.2019.01.007.
(27) De Carvalho Panzeri Carlotti, Ferriani VPL, Caldas CT, Cervi MC, Pileggi G, Carvalho C, et al. Polyarteritis nodosa with central nervous system involvement mimicking meningoencephalitis. Pediatr Crit Care Med. 2004;5(3):286–8. DOI 10.1097/01.PCC.0000124020.21574.2B.
(28) Kang Y, Hong SH, Yoo HJ, Choi JY, Park JK, Park J, et al. Muscle Involvement in Polyarteritis Nodosa: Report of Eight Cases with Characteristic Contrast Enhancement Pattern on MRI. AJR Am J Roentgenol. 2016 Feb;206(2):378-84. DOI 10.2214/AJR.15.14774.
(29) Brogan PA, Davies R, Gordon I, Dillon MJ. Renal angiography in children with polyarteritis nodosa. Pediatr Nephrol. 2002 Apr;17(4):277-83. DOI 10.1007/s00467-002-0823-4.
(30) Talukder MK, Islam MI, Rahman SA. Clinical and laboratory profile of childhood polyarteritis nodosa in a Bangladeshi tertiary hospital. Int J Rheum Dis. 2014 Mar;17(3):313-6. DOI 10.1111/1756-185X.12319.
(31) Nesher G, Oren S, Lijovetzky G, Nesher R. Vasculitis of the temporal arteries in the young. Semin Arthritis Rheum. 2009 Oct;39(2):96-107. DOI 10.1016/j.semarthrit.2008.03.001.
(32) Bert RJ. Polyarteritis Nodosa Presenting as Temporal Arteritis in a 9-year-old Child. AJNR Am J Neuroradiol. 1999;20(1):167–71.
(33) Merlin E, Mouy R, Pereira B, Mouthon L, Bourmaud A, Piette JC, et al. Long-term outcome of children with pediatric-onset cutaneous and visceral polyarteritis nodosa. Joint Bone Spine. 2015 Jul;82(4):251-7. DOI 10.1016/j.jbspin.2015.01.007.
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Universidad de Antioquia
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Papers published in the journal are available for use under the Creative Commons license, specifically Attribution-NonCommercial-ShareAlike 4.0 International.
The papers must be unpublished and sent exclusively to the Journal Iatreia; the author uploading the contribution is required to submit two fully completed formats: article submission and authorship responsibility.
